This paper is in the following e-collection/theme issue:

Myocardial Infarction (Heart Attack) (44) Web-based and Mobile Health Interventions (3297)

Published on in Vol 6, No 2 (2022): Jul-Dec

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2022.02.09.22270713v1, first published .
Use of Digital Technology Tools to Characterize Adherence to Prescription-Grade Omega-3 Polyunsaturated Fatty Acid Therapy in Postmyocardial or Hypertriglyceridemic Patients in the DIAPAsOn Study: Prospective Observational Study

Use of Digital Technology Tools to Characterize Adherence to Prescription-Grade Omega-3 Polyunsaturated Fatty Acid Therapy in Postmyocardial or Hypertriglyceridemic Patients in the DIAPAsOn Study: Prospective Observational Study

Use of Digital Technology Tools to Characterize Adherence to Prescription-Grade Omega-3 Polyunsaturated Fatty Acid Therapy in Postmyocardial or Hypertriglyceridemic Patients in the DIAPAsOn Study: Prospective Observational Study

Authors of this article:

Gregory P Arutyunov1 Author Orcid Image ;   Alexander G Arutyunov1 Author Orcid Image ;   Fail T Ageev2 Author Orcid Image ;   Tatiana V Fofanova2 Author Orcid Image
Article Authors Cited by (1) Tweetations (5) Metrics

Journals

  1. Ezhov M, Arutyunov G. Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome. Diseases 2023;11(4):140 View